Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
No To Five, Yes To Three: NICE Decides On Funding For Drugs In England
NICE To Review Vyndaqel Guidance Quickly If New Pricing Deal Is Reached
May 14 2021
•
By
Neena Brizmohun
NICE assesses the cost effectiveness of drugs • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Market Access